Moderna's Q3: Mixed Results, Bullish Market

Modernas Q3 earnings show mixed results, with revenue of $1.02 billion, a 45.4% drop from last year but beating expectations by $769.6 million. The stock surged 7.7% post-announcement. GAAP loss per share improved by 78.6% but full-year revenue guidance was lowered by 4.4%. Despite positive market reaction, operating margin fell to -25.6%, indicating rising expenses. Overall, a complex outlook for Moderna.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.